SK283451B6 - 3-Substituované 1-arylindolové zlúčeniny, farmaceutické prostriedky s ich obsahom a ich použitie - Google Patents

3-Substituované 1-arylindolové zlúčeniny, farmaceutické prostriedky s ich obsahom a ich použitie Download PDF

Info

Publication number
SK283451B6
SK283451B6 SK758-96A SK75896A SK283451B6 SK 283451 B6 SK283451 B6 SK 283451B6 SK 75896 A SK75896 A SK 75896A SK 283451 B6 SK283451 B6 SK 283451B6
Authority
SK
Slovakia
Prior art keywords
hydrogen
alkyl
group
compound
substituted
Prior art date
Application number
SK758-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK75896A3 (en
Inventor
Kim Andersen
Jens Kristian Perregaard
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of SK75896A3 publication Critical patent/SK75896A3/sk
Publication of SK283451B6 publication Critical patent/SK283451B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SK758-96A 1993-12-16 1994-12-15 3-Substituované 1-arylindolové zlúčeniny, farmaceutické prostriedky s ich obsahom a ich použitie SK283451B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK931395A DK139593D0 (da) 1993-12-16 1993-12-16 Compounds
PCT/DK1994/000470 WO1995016684A1 (en) 1993-12-16 1994-12-15 3-substituted 1-arylindole compounds

Publications (2)

Publication Number Publication Date
SK75896A3 SK75896A3 (en) 1996-11-06
SK283451B6 true SK283451B6 (sk) 2003-08-05

Family

ID=8104386

Family Applications (1)

Application Number Title Priority Date Filing Date
SK758-96A SK283451B6 (sk) 1993-12-16 1994-12-15 3-Substituované 1-arylindolové zlúčeniny, farmaceutické prostriedky s ich obsahom a ich použitie

Country Status (25)

Country Link
US (1) US5789404A (ko)
EP (2) EP0939077A3 (ko)
JP (1) JPH09506595A (ko)
KR (1) KR100363484B1 (ko)
CN (1) CN1080261C (ko)
AT (1) ATE195313T1 (ko)
AU (1) AU682915B2 (ko)
CA (1) CA2179179A1 (ko)
CZ (1) CZ285028B6 (ko)
DE (1) DE69425510T2 (ko)
DK (2) DK139593D0 (ko)
ES (1) ES2149959T3 (ko)
FI (1) FI962496A (ko)
GR (1) GR3034744T3 (ko)
HK (1) HK1013815A1 (ko)
HU (1) HU223318B1 (ko)
IL (1) IL111989A (ko)
NO (1) NO306671B1 (ko)
NZ (1) NZ277483A (ko)
PL (1) PL181253B1 (ko)
PT (1) PT734384E (ko)
RU (1) RU2139287C1 (ko)
SK (1) SK283451B6 (ko)
WO (1) WO1995016684A1 (ko)
ZA (1) ZA949918B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
JP5682051B2 (ja) 2006-05-18 2015-03-11 ファーマサイクリックス，インク． 細胞内キナーゼ阻害剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1220628A (en) * 1968-07-20 1971-01-27 Pfizer Ltd N-phenyl indole derivatives and pharmaceutical compositions thereof
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
DE1911893A1 (de) * 1969-03-08 1970-09-24 Thiemann Gmbh Chem Pharm Fabri Verfahren zur Herstellung von N-(Halogen-aryl)-2-methyl-5-alkoxy-indol-3-essigsaeuren
BE795457A (fr) * 1972-02-16 1973-08-16 Clin Midy Amines indoliques, leur preparation et leur application en therapeutiques
FR2242091A1 (en) * 1973-09-04 1975-03-28 Delalande Sa 1-Phenyl-2-methyl-3-aminomethyl-5-methoxy indole derivs - with e.g. analgesic, antidepressive and anti-arrhythmic props
US4558048A (en) * 1984-04-06 1985-12-10 Pfizer Inc. Method of treating diarrhoea using indole compounds
DE3430284A1 (de) * 1984-08-17 1986-02-27 Troponwerke GmbH & Co KG, 5000 Köln Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
DK152090D0 (da) * 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
DK36391D0 (da) * 1991-03-01 1991-03-01 Lundbeck & Co As H Anvendelse af piperidylsubstituerede indolderivater til behandling af stofmisbrug
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2705346B1 (fr) * 1993-05-18 1995-08-11 Union Pharma Scient Appl Nouveaux dérivés de pipéridinyl thio indole, leurs procédés de préparation, compositions pharmaceutiques les contenant, utiles notamment comme antalgiques .
US5504101A (en) * 1994-05-06 1996-04-02 Allelix Biopharmaceuticals, Inc. 5-HT-1D receptor ligands

Also Published As

Publication number Publication date
NZ277483A (en) 1998-05-27
HK1013815A1 (en) 1999-09-10
CZ285028B6 (cs) 1999-05-12
PT734384E (pt) 2000-12-29
DK0734384T3 (da) 2001-01-02
GR3034744T3 (en) 2001-02-28
EP0734384A1 (en) 1996-10-02
NO962505D0 (no) 1996-06-13
DE69425510T2 (de) 2001-04-19
FI962496A0 (fi) 1996-06-14
IL111989A (en) 2000-10-31
NO306671B1 (no) 1999-12-06
SK75896A3 (en) 1996-11-06
CN1080261C (zh) 2002-03-06
WO1995016684A1 (en) 1995-06-22
CZ172796A3 (en) 1996-11-13
ZA949918B (en) 1995-08-23
JPH09506595A (ja) 1997-06-30
AU682915B2 (en) 1997-10-23
ATE195313T1 (de) 2000-08-15
DE69425510D1 (de) 2000-09-14
KR960706492A (ko) 1996-12-09
KR100363484B1 (ko) 2003-02-05
US5789404A (en) 1998-08-04
CA2179179A1 (en) 1995-06-22
CN1142824A (zh) 1997-02-12
HU223318B1 (hu) 2004-05-28
HU9601640D0 (en) 1996-08-28
ES2149959T3 (es) 2000-11-16
IL111989A0 (en) 1995-03-15
RU2139287C1 (ru) 1999-10-10
PL181253B1 (pl) 2001-06-29
AU1272195A (en) 1995-07-03
HUT76276A (en) 1997-07-28
FI962496A (fi) 1996-06-14
EP0939077A3 (en) 2003-11-19
PL315027A1 (en) 1996-09-30
DK139593D0 (da) 1993-12-16
EP0939077A2 (en) 1999-09-01
EP0734384B1 (en) 2000-08-09
NO962505L (no) 1996-08-12

Similar Documents

Publication Publication Date Title
JP3833116B2 (ja) ビフェニル誘導体、その製法及び薬剤としての使用
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
DK158942B (da) 3-(2-(dimethylamino)ethyl)-n-methyl-1h-indol-5-methansulfonamid, farmaceutiske praeparater indeholdende denne forbindelse samt fremgangsmaader til fremstilling af forbindelsen
CA2048027C (en) 3-arylindole and 3-arylindazole derivatives
EP0714896A1 (en) Indol derivatives useful for the treatment of migraine, composition and utilization
SK11062002A3 (sk) Fenylpiperazínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
SK280881B6 (sk) Derivát 3-indolylpiperidínu, spôsob jeho prípravy, jeho použitie na prípravu farmaceutického prostriedku a farmaceutický prostriedok, ktorý ho obsahuje
US5049576A (en) Carboxamide derivatives
WO1998031669A1 (fr) Nouvelles arylpiperazines derivees de piperidine comme medicaments antidepresseurs
JP3898219B2 (ja) フエニルインドール化合物
SK283451B6 (sk) 3-Substituované 1-arylindolové zlúčeniny, farmaceutické prostriedky s ich obsahom a ich použitie
AU780027B2 (en) New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them
EP0666847B1 (en) Tryptamine analogs with 5-ht1d selectivity
WO1996026936A1 (fr) Nouveaux derives de piperazine amino-indole cycliques, leur procede de preparation et leur utilisation a titre de medicaments
US6133453A (en) Method for making substituted indoles
CA2587936A1 (en) Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
FR2731224A1 (fr) Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments